Related Experiment Video
Updated: Aug 13, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
[Evaluation of nonpharmacologic invasive treatment in cardiology: the example of implantable automatic
1Service de Cardiologie A, Hôpital Broussais, Paris, France.
Abstract:
Substantial therapeutic advances have been achieved in cardiology in the last fifteen years. They are due to the progress of cardiovascular pharmacology and interventional cardiology. Many devices are now competing with drugs. In France, the evaluation procedures of these two types of treatment are highly different. The benefit/risk ratio is not evaluated sufficiently before the marketing authorization of the devices. The procedures leading to reimbursement by Social Security are completely different for the drugs and the devices, and harmonization of these procedures is essential. It could allow the avoidance of paradoxical situations such as that of the automatic implantable defibrillator whose efficacy is now validated by controlled studies; but payment for which is not reimbursed by Social Security. The consequence is a serious dearth of this item, the implantation ratio per million residents in France being lower than that of all neighbouring countries.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

